SMARCA4 regulates the NK-mediated killing of senescent cells

Virinder Reen1,2, Mariantonietta D'Ambrosio1,2, Pia Pernille Søgaard1,2

  • 1MRC Laboratory of Medical Sciences (LMS), Du Cane Road, London W12 0NN, UK.

Science Advances
|January 15, 2025
PubMed

Insights

Targeting SMARCA4 enhances natural killer (NK) cell elimination of senescent cancer cells. This senotherapeutic approach boosts immune surveillance and may improve ovarian cancer treatment outcomes.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Chemotherapy-induced senescence can arrest cancer cells but requires immune clearance for optimal outcomes.
  • Natural killer (NK) cells are crucial for eliminating senescent cells and enhancing anti-cancer immunity.
  • Enhancing NK cell-mediated killing of senescent cells is a promising therapeutic strategy.

Purpose of the Study:

  • To identify novel targets for enhancing NK cell-mediated elimination of senescent cancer cells.
  • To investigate the role of SMARCA4 in regulating the immune response to senescent cells.
  • To evaluate SMARCA4 inhibition as a senotherapeutic strategy for ovarian cancer.

Main Methods:

  • Utilized a staggered siRNA screen to identify genes potentiating immunomodulatory cytokine secretion.
  • Assessed the ability of identified siRNAs to enhance NK cell-mediated killing of senescent cells.
  • Investigated the molecular mechanisms of SMARCA4 inhibition, including repetitive element derepression and SASP induction via cGAS/STING and MAVS/MDA5 pathways.
  • Tested a PROTAC targeting SMARCA4 in combination with cisplatin in an immunocompetent ovarian cancer model.

Main Results:

  • Genetic or pharmacological inhibition of SMARCA4 significantly enhanced NK cell-mediated elimination of senescent cells.
  • SMARCA4 expression is upregulated during senescence; its inhibition leads to derepression of repetitive elements and induction of the senescence-associated secretory phenotype (SASP).
  • SMARCA4 inhibition activates the cGAS/STING and MAVS/MDA5 pathways.
  • A SMARCA4-targeting PROTAC synergized with cisplatin to increase CD8 T cell and activated NK cell infiltration in an ovarian cancer model.

Conclusions:

  • SMARCA4 inhibition enhances NK cell-mediated surveillance of senescent cells.
  • Targeting SMARCA4 represents a potential senotherapeutic intervention for ovarian cancer.
  • This approach may improve treatment efficacy by boosting anti-tumor immune responses.

Related Concept Videos

Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
1.4K
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
1.3K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.2K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
3.7K
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K